How will immunotherapy change the future of bladder Ca care? – ModernMedicine
ModernMedicine |
How will immunotherapy change the future of bladder Ca care?
ModernMedicine Urology Times reached out to three urologists (selected randomly and asked them each the following question: How will immunotherapy change the future of bladder Ca care? Dr. Dickstein“It’s an exciting time in bladder cancer because for many years we’ve … |
The Guardian |
Cancer patients’ grey hair unexpectedly darkens in drug study
The Guardian Chemotherapy is known to make patients’ hair fall out, but the 14 people involved were all being treated with new immunotherapy drugs that work differently and have different side effects from chemotherapy. A Spanish study suggests those may include … |
U.S. News & World Report |
No Dye: Cancer Patients’ Gray Hair Darkened on Immune Drugs
U.S. News & World Report This undated combination of photos provided by the Journal of the American Medical Association in July 2017 shows a cancer patient with gray hair that unexpectedly turned dark while taking new immunotherapy drugs. Fourteen such cases were among 52 … Cancer patients’ grey hair unexpectedly darkens in drug studyThe Guardian No dye: Cancer patients’ gray hair darkened on immune drugs – The …The Edwardsville Intelligencer |
|
TDU launches seminar series to support outlining international and national policy on synthetic biology
Daily News & Analysis Synthetic Biology is bringing together disparate disciplines like engineering, computer science, biotechnology and molecular biology to revolutionise the way we live. But how can India be a part of this revolution? The TransDisciplinary University (TDU … |
|
Novel CRISPR-Cas9 screening enables discovery of new targets to aid cancer immunotherapy
Science Daily “The challenge so far has been finding the most effective immunotherapy targets and prioritizing those that work best when combined with PD-1 inhibitors,” Haining says. “So, we set out to develop a better system for identifying new drug targets that … |
|
QoL better with bladder Ca immunotherapy vs. chemo
ModernMedicine Chicago—Patients treated with pembrolizumab (Keytruda) as second-line therapy for advanced urothelial carcinoma (UC) following platinum-based chemotherapy maintain better health-related quality of life (HRQoL) than their counterparts receiving … |